Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 5
2021 6
2022 7
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Tominersen in Adults with Manifest Huntington's Disease.
McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, Zhou J, Schlegel V, Sanwald Ducray P, Hawellek DJ, Dorn J, Simillion C, Lindemann M, Wheelock V, Durr A, Anderson KE, Long JD, Wild EJ, Landwehrmeyer GB, Leavitt BR, Tabrizi SJ, Doody R; GENERATION HD1 Investigators. McColgan P, et al. N Engl J Med. 2023 Dec 7;389(23):2203-2205. doi: 10.1056/NEJMc2300400. N Engl J Med. 2023. PMID: 38055260 No abstract available.
Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study.
Sidoroff V, Carbone F, Ellmerer P, Bair S, Hoffmann A, Maran T, Krismer F, Mahlknecht P, Mair K, Raccagni C, Ndayisaba JP, Seppi K, Wenning GK, Djamshidian A. Sidoroff V, et al. Among authors: ellmerer p. J Mov Disord. 2024 Jan;17(1):38-46. doi: 10.14802/jmd.23090. Epub 2023 Sep 26. J Mov Disord. 2024. PMID: 37748924 Free PMC article.
Body Composition and Physical Performance 1 Year After COVID-19.
Peball M, Rass V, Valent D, Beer R, Schiefecker AJ, Limmert V, Putnina L, Heim B, Ellmerer P, Carbone F, Mahlknecht P, Kofler M, Lindner A, Kindl P, Sahanic S, Coen M, Pizzini A, Pfausler B, Kiechl S, Sonnweber T, Tancevski I, Löffler-Ragg J, Djamshidian A, Helbok R, Seppi K. Peball M, et al. Among authors: ellmerer p. Am J Phys Med Rehabil. 2024 Feb 1;103(2):124-133. doi: 10.1097/PHM.0000000000002314. Epub 2023 Jul 6. Am J Phys Med Rehabil. 2024. PMID: 37408132
Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease.
Peball M, Valent D, Grossauer A, Marini K, Ellmerer P, Wallnöfer J, Krismer F, Djamshidian A, Seppi K, Heim B. Peball M, et al. Among authors: ellmerer p. J Parkinsons Dis. 2023;13(3):341-350. doi: 10.3233/JPD-225108. J Parkinsons Dis. 2023. PMID: 37005894 Free PMC article.
Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking.
Carbone F, Zamarian L, Rass V, Bair S, Ritter M, Beer R, Mahlknecht P, Heim B, Limmert V, Peball M, Ellmerer P, Schiefecker AJ, Kofler M, Lindner A, Pfausler B, Putnina L, Kindl P, Löffler-Ragg J, Kiechl S, Seppi K, Djamshidian A, Helbok R. Carbone F, et al. Among authors: ellmerer p. Ann Clin Transl Neurol. 2022 Nov;9(11):1826-1831. doi: 10.1002/acn3.51675. Epub 2022 Oct 20. Ann Clin Transl Neurol. 2022. PMID: 36264758 Free PMC article.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
25 results